Related Experiment Video
Updated: Jan 19, 2026

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Canagliflozin and Renal Outcomes in Diabetic Nephropathy
Bruce R Leslie1, Leslie E Gerwin2
1Seventh Doctor Consulting, Princeton, NJ seventhdoctor@gmail.com.
No abstract available in PubMed .
Related Concept Videos
08:15Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
11:18Direct Drug Delivery to Kidney via the Renal Artery
10:03A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Predicting Reaction Outcomes
14:18Dioscin Mediated IgA Nephropathy Alleviation by Inhibiting B Cell Activation In Vivo and Decreasing Galactose-Deficient IgA1 Production In Vitro

